The rate of AED use in the elderly nursing home population exceeds 10 % yet, the rate of AED use of epilepsy is highest in the elderly and the group of people 65 years of age and older is the most rapidly growing segment of the U.S. population. No research has been reported describing the epidemiological rates of AED use or whether or not AEDs are prescribed differently for subgroups of patients in the elderly by age, sex, or racial groups; nor is it known what outcomes such as basic activities of daily living are associated with the use of AEDs. The focus of this project is on the pharmacoepidemiology of AED use among those who are nursing home residents and will use a population of over 65,000 patients in managed care nursing home settings.
The specific aims are: 1) to determine the prevalence of a documented diagnosis of epilepsy or seizures and patient characteristics associated with use of antiepileptic drug (AED) treatment by nursing home residents; 2) to determine the prevalence of and patient characteristics associated with AED monotherapy and polypharmacy among nursing home residents 3) to determine for a cohort of nursing home admissions the AED prevalence upon admission and incidence following admission, the diagnostic and patient indicators of use, and the dosage and duration of treatment during their first year of nursing home residency; and 4) to determine patient outcomes associated with AED treatment in a cohort of nursing home admissions. This is a 5 year collaborative study among faculty at the University of Minnesota. The project's multidisciplinary team includes the disciplines of psychology, pharmacy, biostatistics, and neurology. Primary and secondary source data will be obtained from Beverly Enterprises, a for-profit nursing home chain based throughout the U.S. Data will include automated files of prescription drugs, and clinical, and sociodemographic characteristics of patients serviced from the MDS (Minimum Data Set) which is collected uniformly across the U.S. The results of this health services research study of antidepressant treatment will have implications for decision-making by primary care physicians, neurologists, patients and their families, health care organizations, and policy makers at the state and federal levels, who presently leave little information regarding this vulnerable population.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS016308-17A1
Application #
6243493
Study Section
Project Start
1997-07-15
Project End
1998-05-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
17
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Conway, Jeannine M; Eberly, Lynn E; Collins, Joseph F et al. (2017) Factors in Variability of Serial Gabapentin Concentrations in Elderly Patients with Epilepsy. Pharmacotherapy 37:1197-1203
Polepally, Akshanth R; Remmel, Rory P; Brundage, Richard C et al. (2015) Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology. J Clin Pharmacol 55:1101-8
Patel, Sima I; Birnbaum, Angela K; Cloyd, James C et al. (2015) Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy. CNS Drugs 29:1009-22
Conway, Jeannine M; Birnbaum, Angela K; Leppik, Ilo E et al. (2014) Safety of an intravenous formulation of lamotrigine. Seizure 23:390-2
Ghodke-Puranik, Yogita; Thorn, Caroline F; Lamba, Jatinder K et al. (2013) Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics 23:236-41
Ahmed, Ghada F; Brundage, Richard C; Marino, Susan E et al. (2013) Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy. J Clin Pharmacol 53:276-84
Puranik, Yogita Ghodke; Birnbaum, Angela K; Marino, Susan E et al. (2013) Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Pharmacogenomics 14:35-45
Punyawudho, Baralee; Ramsay, Eugene R; Brundage, Richard C et al. (2012) Population pharmacokinetics of carbamazepine in elderly patients. Ther Drug Monit 34:176-81
Marino, S E; Birnbaum, A K; Leppik, I E et al. (2012) Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex. Clin Pharmacol Ther 91:483-8
Leppik, Ilo E; Walczak, Thaddeus S; Birnbaum, Angela K (2012) Challenges of epilepsy in elderly people. Lancet 380:1128-30

Showing the most recent 10 out of 96 publications